VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Syndax (NASDAQ: SNDX)

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 79 out of 100

At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before.

Also known as Syndax

  • Biotech & therapeutics
Business model
B2B
Claim, correct or request removal

Record updated 28 September 2026

About

Syndax’s mission is to obtain regulatory approval and commercialize drugs that extend and improve the lives of cancer patients by drawing on the newest scientific research and advances, collaborating with determined problem solvers, and identifying value in overlooked aspects of science.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy